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Edited by Robert BaroukiAbstract With two tandem repeated cysteine- and histidine-rich
domains (designated as CHORD), CHORD-containing proteins
(CHPs) are a novel family of highly conserved proteins that play
important roles in plant disease resistance and animal develop-
ment. Through interacting with suppressor of the G2 allele of
Skp1 (SGT1) and Hsp90, plant CHORD-containing protein
RAR1 (required for Mla resistance 1) plays a critical role in
disease resistance mediated by multiple R genes. Yet, the physi-
ological function of vertebrate CHORD-containing protein-1
(Chp-1) has been poorly investigated. In this study, we provide
the ﬁrst biochemical evidence demonstrating that mammalian
Chp-1 is a novel Hsp90-interacting protein. Mammalian Chp-1
contains two CHORD domains (I and II) and one CS domain
(a domain shared by CHORD-containing proteins and SGT1).
With sequence and structural similarity to Hsp90 co-chaperones
p23 and SGT1, Chp-1 binds to the ATPase domain of Hsp90,
but the biochemical property of the interaction is unique. The
Chp-1–Hsp90 interaction is independent of ATP and ATPase-
coupled conformational change of Hsp90, a feature that distin-
guishes Chp-1 from p23. Furthermore, it appears that multiple
domains of Chp-1 are required for stable Chp-1–Hsp90 interac-
tion. Unlike SGT1 whose CS domain is suﬃcient for Hsp90
binding, the CS domain of Chp-1 is essential but not suﬃcient
for Hsp90 binding. While the CHORD-I domain of Chp-1 is dis-
pensable for Hsp90 binding, the CHORD-II domain and the lin-
ker region are essential. Interestingly, the CHORD-I domain of
plant RAR1 protein is solely responsible for Hsp90 binding. The
unique Chp-1–Hsp90 interaction may be indicative of a distinct
biological activity of Chp-1 and functional diversiﬁcation of
CHORD-containing proteins during evolution.
 2004 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Recent studies have revealed that plants and animals may
have adopted a similar strategy in defending microbial infec-
tion [1]. The plant resistance (R) genes that speciﬁcally recog-
nize pathogen avirulence (avr) gene products mediate localized
plant cell death (hypersensitive response HR) and trigger sys-
temic immunity [2]. In animals, the nucleotide-binding (NB)
oligomerization domain (NOD) proteins, which structurally
resemble a subclass of plant R proteins, are involved in intra-
cellular recognition of pathogens and initiation of inﬂamma-
tory response [3]. These ﬁndings strongly indicate that the
molecular mechanism for innate immunity is highly conserved
during evolution.
More recently, genetic studies in plants have identiﬁed a few
molecules that are crucial components of R gene-mediated
plant disease resistance, including RAR1 (required for Mla
resistance 1) [4], SGT1 (suppressor of the G2 allele of Skp1)
[5,6] and Hsp90 (heat shock protein 90) [7–9]. RAR1 and
SGT1 not only interact with each other [5], but also speciﬁcally
interact with Hsp90 as well [8,9], indicating that RAR1 and
SGT1 may function as co-chaperones of Hsp90 in processes
essential for plant disease resistance. RAR1, SGT1 and
Hsp90 are highly conserved in eukaryotic genomes. The
Hsp90 family represents one of the major chaperone protein
families and plays crucial roles in multiple signal transduction
pathways [10,11]. Human cytosolic Hsp90 (Hsp90a and
Hsp90b) contains the carboxy-terminal (C-terminal) dimeriza-
tion domain, the amino-terminal (N-terminal) ATPase domain
and the central domain that are crucial for ATPase-coupled
conformational cycle and interactions with co-chaperone and
client proteins [12]. Both N- and C-terminal domains have also
been implicated in interactions with substrates and a cohort of
co-chaperone proteins [10,13]. SGT1 is highly conserved from
yeast to human. In addition to its interaction with RAR1 in
plants, SGT1 interacts with yeast Skp1, a component of
Skp1-Cul1-F-box (SCF) E3 ubiquitin complex [14]. Sequence
analysis and structural prediction indicate that SGT1 consists
of three conserved domains: the N-terminal region containing
a tetratricopeptide repeat (TPR) motif, the central CS domain
(a domain shared by CHORD-containing proteins and SGT1)
that is similar to Hsp90 co-chaperone p23 and responsible for
Hsp90 binding [15,16], and the C-terminal SGS (SGT1-spe-
ciﬁc) domain that interacts with S100 calcium-binding proteins
[17].blished by Elsevier B.V. All rights reserved.
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Plant RAR1 contains two highly similar but distinct cysteine-
and histidine-rich Zn2+-binding domains (designated as
CHORD) that are conserved in eukaryotic phyla except yeast.
In addition to two CHORD domains (CHORD-I and
CHORD-II), metazoan CHORD-containing proteins contain
a C-terminal CS domain. While plants and invertebrates (C.
elegans and Drosophila) have one CHORD-containing protein,
two CHORD-containing proteins, CHORD-containing pro-
tein 1 (Chp-1) and Melusin, have been identiﬁed in vertebrates.
Melusin is a muscle-speciﬁc integrin-binding protein that is in-
volved in cardiomyocyte hypertrophy response [18,19]. In con-
trast, Chp-1 is ubiquitiously expressed in all tissues and cells
examined so far [20, and our unpublished data]. Sequence
analysis further suggests that vertebrate Chp-1 is the homolog
of invertebrate Chp-1, while Melusin may be originated from
gene duplication during evolution [20]. Silencing of Caenorhab-
ditis elegans Chp-1 results in semi-sterility and embryonic
lethality, indicating an essential role of Chp-1 in nematode
development [4]. Despite its crucial role in animal develop-
ment, how metazoan Chp-1 exerts its function remains largely
unclear. In an attempt to elucidate the function of Chp-1, we
report here the identiﬁcation of mammalian Chp-1 as a novel
Hsp90-interacting protein.2. Materials and methods
2.1. Tissue culture cells and reagents
HEK 293 and PC3 cells (from ATCC) were cultured in Dulbeccos
modiﬁed Eagles medium supplemented with 10% fetal bovine serum
and antibiotics. Anti-Flag M2 antibody and other reagents were pur-
chased from Sigma. Anti-human Hsp90 antibody was purchased from
Santa Cruz Biotech Inc. and human puriﬁed Hsp90 protein was from
Stressgen. Geldanamycin was from Invivogen.
2.2. cDNA cloning, construction of expression vectors
Murine Chp-1 gene was ampliﬁed from an EST clone containing
full-length Chp-1 cDNA and subcloned into pCMV-5a for expressing
C-terminal Flag-tagged Chp-1 protein. Full-length human Hsp90b
cDNA was obtained from IMAGE clone 3621040 and subcloned into
pACT2 for yeast two-hybrid assay. DNA fragments of the deletion
mutants of Chp-1 and Hsp90 were obtained by PCR using appropriate
primers. Glutathione S-transferase (GST) fusion protein was puriﬁed
using glutathione–Sepharose 4B beads according to the suppliers
instructions (Amersham–Pharmacia).
2.3. Production of Chp-1 antibodies
His-tagged murine Chp-1 fusion protein was puriﬁed using Ni–NTA
column (Novagen) according to the suppliers instructions and used as
antigen for generation of rat polyclonal antibodies. The Chp-1 poly-
clonal antibody used in this study was tested to speciﬁcally recognize
both human and murine Chp-1 but not human Melusin (Wu and Li,
unpublished data).
2.4. Co-immunoprecipitation assay
Construct of Chp-1 (pCMV-Chp-1) was transiently transfected into
293 cells, followed by 24-h incubation. Cells were harvested and washed
with phosphate-buﬀered saline (PBS), and resuspended in lysis buﬀer
(20 mM Tris, pH 7.2, 150 mM NaCl, 1% NP-40, 1 mM DTT, 1 mM
EDTA and a cocktail of protease inhibitors). After incubation for 15
min on ice, cell lysates were cleared by 15-min centrifugation at 13000
rpm. The resulting supernatant was incubated with agarose-conjugated
anti-Flag M2 antibody (Sigma) for 3 h at 4 C. After three washes with
lysis buﬀer, the beads were eluted with 0.1 M glycine (pH 2.5), and the
samples were subjected to electrophoresis and immunoblotting or silver
staining. To investigate the interaction of endogenous Chp-1 and
Hsp90, we lysed PC3 cells in low-salt binding buﬀer. PC3 cells(3 · 106) were resuspended in binding buﬀer (20 mM HEPES, pH 7.5,
0.01% NP-40, 10 mM NaCl, 5 mM MgCl2, 1 mM DTT, and 1 mM
EDTA) containing a cocktail of protease inhibitor and lysed by three cy-
cles of freeze–thaw. After centrifugation at 13000 rpm for 15 min, the
supernatant was incubated with 2 lg of anti-Hsp90 monoclonal anti-
body (F-8) (Santa Cruz Biotech. Inc.) or control antibody (anti-cytoker-
atin-18, Santa Cruz Biotech. Inc.) at 4 C for 3 h, and followed by extra
one-hour incubation with Ultralink immobilized protein A/G (Pierce)
beads. After three washes of beads with the binding buﬀer, the bound
proteins were eluted with 0.1 M glycine (pH 2.5) and subjected to elec-
trophoresis and immunoblotting with speciﬁc antibodies.
2.5. In vitro GST pull-down assay
Puriﬁed Hsp90 (Stressgen) was incubated with or without 1 mM
ATP or ATP-cS for 30 min at 30 C in binding buﬀer (20 mM HEPES,
pH 7.5, 0.01% NP-40, 10 mM NaCl, 5 mM MgCl2, 1 mM DTT, and 1
mM EDTA), in the presence of an ATP regenerating system including
7 units of creatine phosphokinase and 10 mM phosphocreatine. 1 lg of
pre-treated Hsp90 was incubated with immobilized GST-fusion pro-
teins of Chp-1 or its deletion mutants (Chp-1-N and Chp-1-C), or
other control proteins (GST, GST-BID) for 1 h at 4 C. GST-fusion
protein beads were then washed three times with the binding buﬀer
and bound proteins were eluted with protein sample buﬀer. After
SDS–PAGE, Hsp90 was visualized by immunoblotting with anti-
Hsp90 antibody.
2.6. Yeast two-hybrid assay
MATCHMAKERGal4 two-hybrid system 3 (Clontech) was used for
our yeast two-hybrid assay. Brieﬂy, Chp-1 and its deletionmutants were
subcloned into pGBKT7 vector, while Hsp90b and its deletion mutants
were subcloned into pACT2 vector. Both pGBKT7-Chp-1 and pACT2-
Hsp90b were transformed into AH109 yeast cells. The Chp-1–Hsp90b
interaction was indicated by growth of transformants on SD/-Ade/-
His/-Leu/-Trp plate and positive X-gal staining. b-Galactosidase liquid
assay was performed using o-nitrophenyl b-D-galactopyranoside
(ONPG) as substrate according to a protocol provided by Clontech.3. Results
3.1. Hsp90 co-immunoprecipitates with Chp-1
In an attempt to identify potential Chp-1 interacting pro-
teins, we overexpressed Chp-1-Flag fusion protein in
HEK293 cells and used anti-Flag antibody M2 to immunopre-
cipitate Chp-1 protein. As shown in Fig. 1A, two bands
around 90 kDa (indicated by arrowheads) were speciﬁcally
present in the immunoprecipitate of Chp-1 but not the
N-terminal fragment of Chp-1 (Chp-1-N, including two
CHORD domains, also see Fig. 4A), even though more
Chp-1-N protein was in the immunoprecipitate. After isolation
of two bands and identiﬁcation by mass spectrometry, two
bands turned out to represent two isoforms of human Hsp90
(a and b). To validate our ﬁnding, we used anti-Hsp90 anti-
body to examine the presence of Hsp90 in the Chp-1-Flag
immunoprecipitate. As illustrated in Fig. 1B, Hsp90 was in-
deed present in the immunoprecipitate of full length Chp-1
but not Chp-1-N. We further examined whether endogenous
Chp-1 and Hsp90 associate in vivo. As shown in Fig. 1C,
endogenous Chp-1 was present in the immunoprecipitate of
Hsp90. Taken together, our result indicates that mammalian
Chp-1 likely associates with Hsp90.3.2. Chp-1 directly binds to Hsp90 in an ATP-independent
manner
In addition to our observation described above, recent evi-
dence suggesting that plant CHORD-containing protein
RAR1 directly interacts with Hsp90 prompted us to investigate
Fig. 1. Hsp90 co-immunoprecipitates with mammalian Chp-1 protein.
(A) Silver staining of the immunoprecipitate of Chp-1-Flag fusion
protein. Chp-1-Flag (full-length Chp-1) or Chp-1-N-Flag (residues #1
to 216, also see Fig. 4A) fusion proteins were overexpressed in
HEK293 cells and immunoprecipitated with anti-Flag M2 antibody.
The samples were subjected to SDS–PAGE and detected with silver
staining kit (Amersham–Pharmcia). Doublet bands around 90 kDa
were excised and subjected to mass spectrometry. Identities of speciﬁc
bands are indicated by arrows. A possible Chp-1 dimer is marked by
star. (B) Immunoblotting of Hsp90 in Chp-1-Flag immunoprecipitate.
The immunoprecipitate of Chp-1-Flag was immunoblotted with Hsp90
and Flag antibodies, respectively. (C) Endogenous Chp-1 associates
with Hsp90. Endogenous Hsp90 was immunoprecipitated down by
Hsp90 antibody and followed by immunoblotting with anti-Chp-1
antibody. Anti-cytokeratin 18 monoclonal antibody was used as the
control antibody.
Fig. 2. Chp-1 directly interacts with Hsp90 in an ATP-independent
manner. (A) GST pull-down assay. 1 lg of pre-treated puriﬁed Hsp90
was incubated with immobilized GST-fusion proteins of Chp-1 or its
deletion mutants (Chp-1-N and Chp-1-C), or other control proteins
(GST, GST-BID) for 1 h at 4 C. After washes and electrophoresis,
Hsp90 was visualized by immunoblotting with anti-Hsp90 antibody.
The lower panel shows puriﬁed GST fusion proteins detected by
Coomassie Blue staining. The star indicates an unknown protein co-
puriﬁed with GST-Chp-1-C. (B) Chp-1–Hsp90 interaction is ATP-
independent. Indicated amounts of ATP, ATP-cS or GA were included
in the in vitro binding assay and the bound Hsp90 was detected by
immunoblotting.
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We developed an in vitro GST pull-down assay using puriﬁed
Hsp90 and GST fusion proteins. As shown in Fig. 2A, Hsp90
speciﬁcally bound to puriﬁed GST–Chp-1 fusion protein but
not control proteins such as GST and GST-BID, indicating
a direct and speciﬁc interaction between Hsp90 and Chp-1.
In agreement with the result of co-immunoprecipitation assay,
Hsp90 did not bind to truncated Chp-1 proteins (either N-ter-
minal or C-terminal fragments of Chp-1, Figs. 2A and 4), fur-
ther demonstrating the speciﬁcity of Chp-1–Hsp90 interaction.
The CS domain of Chp-1 protein shares sequence and struc-
tural homology with Hsp90 co-chaperone protein p23 [15].
The fact that Hsp90–p23 interaction is ATP-dependent led
us to examine whether ATP is required for Chp-1–Hsp90
interaction and whether the presence of ATP aﬀects their inter-
action [21]. Since ATP was not included in our initial co-immu-
noprecipitation and pull-down assays, it appeared likely that
the interaction between Chp-1 and Hsp90 is ATP-independent.
As shown in Fig. 2B, inclusion of either ATP or its non-hydro-
lyzable analog ATP-cS in the binding reactions did not alter
the Chp-1–Hsp90 interaction. Moreover, geldanamycin
(GA), an ansamycin antibiotic that speciﬁcally inhibits ATP
binding and ATP-dependent Hsp90 chaperone activity by
binding to a conserved binding pocket in the N-terminal do-
main of Hsp90, neither blocked nor reduced the Chp-1–
Hsp90 interaction even at high concentrations (Fig. 2B). This
result clearly demonstrates that in vitro Chp-1–Hsp90 interac-
tion is ATP-independent and that ATPase-coupled conforma-
tional change of Hsp90 may not be required for Chp-1
binding.3.3. The ATPase domain of Hsp90 interacts with Chp-1
A number of domains or regions have been deﬁned for
Hsp90s chaperone activity and its interactions with co-chaper-
ones and client proteins. Small co-chaperone protein p23 binds
to the N-terminal domain of Hsp90, whereas most of the TPR
proteins (proteins with tetratricopeptide motifs such as Hop,
CHIP) interact with the C-terminal domain that contains the
pentapeptide MEEVD (Fig. 3A) [11,13]. We developed a yeast
two-hybrid assay to evaluate speciﬁc interaction between
Hsp90 and Chp-1. As shown in Fig. 3B, Chp-1 speciﬁcally
interacted with both Hsp90a and Hsp90b in yeast two-hybrid
assays (construct #1 and our unpublished data). In an attempt
to map the domains of Hsp90 responsible for Chp-1–Hsp90
interaction, we made a series of deletion mutants of Hsp90.
The pentapeptide MEEDV of Hsp90b (construct #2) was dis-
pensable for Chp-1–Hsp90 interaction, so was the whole C-ter-
minal half of the protein (constructs #3–5) (Fig. 3B). In
contrast, the N-terminal ATPase domain (residues 1 to 228)
was suﬃcient for Chp-1 binding (construct #5), while the N-
terminal region of 1–92 residues was essential (construct #6).
Except for the ATPase domain, the dimerization domain and
any other regions or sequences of Hsp90 did not interact with
Chp-1 (constructs #5, 7 and 8). Interestingly, X-gal ﬁlter assay
showed slightly stronger interactions between Chp-1 and
Hsp90 C-terminal deletion mutants (constructs #3–5) than
the one between Chp-1 and full-length Hsp90 (Fig. 3B).
Fig. 3. The ATPase domain of Hsp90 is essential and suﬃcient for its interaction with Chp-1. (A) Functional domains of human Hsp90b. (B)
Identiﬁcation of Hsp90 domains responsible for Chp-1–Hsp90 interaction by yeast two-hybrid assays. MATCHMAKER Gal4 two-hybrid system 3
(Clontech) was used for yeast two-hybrid assay. Chp-1 and its deletion mutants were subcloned into pGBKT7 vector, while Hsp90b and its deletion
mutants were subcloned into pACT2 vector. Both pGBKT7-Chp-1 and pACT2-Hsp90b were co-transformed into AH109 yeast cells. Interaction of
Chp-1 and Hsp90b was indicated by the growth of transformants on SD/-Ade/-His/-Leu/-Trp plate and positive X-gal staining. Intensities of X-gal
staining were scored by visual examination. b-Galactosidase liquid culture assay was performed using ONPG as substrate. 1 unit of b-galactosidase is
deﬁned as the amount which hydrolyzes 1 lmol of ONPG to o-nitrophenol and D-galactose per minute per cell. The data are expressed as
means ± S.D. and obtained with at least three independent yeast clones.
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In plant, the CHORD-I domain of RAR1 is the only
domain required for Hsp90 binding [8,9]. However, mamma-
lian Chp-1 contains both CHORD and CS domains that
potentially bind to Hsp90 (Fig. 4A) [16]. To further map the
domains of Chp-1 essential for Hsp90 binding, we made a ser-
ies of Chp-1 deletion mutants and tested their interactions with
Hsp90 in yeast two-hybrid assays. As shown in Fig. 4B, neither
Chp-1-N (construct #4) nor Chp-1-C (construct #7) interacted
with Hsp90, indicating that neither CHORD domains nor CS
domain of Chp-1 alone are suﬃcient for Hsp90 binding (Fig.
4B). Deletion of CHORD-I (construct #5) had no eﬀect, sug-
gesting that CHORD-I is dispensable for Chp-1–Hsp90 inter-
action (Fig. 4B). However, deletion of a part of CS domain
(construct #3) completely abolished Chp-1–Hsp90 interaction.
Interestingly, deletion of CHORD-I and the linker region be-
tween two CHORD domains (construct #6) severely weakened
the interaction, even though a very weak interaction was con-
sistently detected by both X-gal ﬁlter assay and b-gal liquid
culture assay (Fig. 4B). Taken together, our data indicate that
multiple domains of Chp-1 are required for stable Chp-1–
Hsp90 interaction.4. Discussion
CHORD-containing proteins (CHPs) are a novel family of
highly conserved proteins that play important roles in plantdisease resistance and animal development. Through interact-
ing with SGT1 and Hsp90, plant CHORD-containing protein
RAR1 plays a critical role in disease resistance mediated by
multiple R genes, yet the molecular mechanism of RAR1-med-
iated signaling remains to be further deﬁned [4]. In vertebrates,
the physiological function of Chp-1 has not yet been fully
investigated. In this study, we provide the ﬁrst biochemical
evidence demonstrating that mammalian Chp-1 is a novel
Hsp90-interacting protein. Given the sequence and structural
similarity between Chp-1 and Hsp90 co-chaperones p23
and SGT1, it is likely that Chp-1 functions as an Hsp90 co-
chaperone.
Among the major molecular chaperones, Hsp90 is distin-
guished from other chaperones in that most of its known sub-
strates (or client proteins) are signaling molecules involved in
the regulation of cell growth, cell proliferation and cell death,
yet its substrate speciﬁcity is less well-deﬁned [10,11,13]. Hsp90
usually operates with a cohort of co-chaperones that modulate
its substrate recognition, ATPase-coupled conformational
cycle and chaperone function. Among them, p23 is a small
acidic protein with chaperone activity by itself and also inter-
acts with the N-terminal domain of ATP-bound Hsp90.
Although p23 does not aﬀect ATPase activity of Hsp90, it pro-
motes the ATP hydrolysis-dependent dissociation of Hsp90–
substrate complexes [21]. Recently, a conserved domain has
been identiﬁed among p23, Hsp20 proteins, the CS domain
of CHORD-containing proteins and SGT1 as well as other
proteins [15]. Given its similarity to p23 and SGT1, Chp-1
may also act as a co-chaperone of Hsp90. Our study clearly
Fig. 4. Multiple domains of Chp-1 are required for Chp-1–Hsp90 interaction. (A) Structural domains of murine Chp-1. (B) Identiﬁcation of Chp-1
domains required for Chp-1–Hsp90 interaction by yeast two-hybrid assays. The experimental procedures were described as in Fig. 3B.
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ATPase domain of Hsp90, and the interaction is independent
of ATP and conformational change of Hsp90. In contrast,
the p23–Hsp90 interaction is strictly ATP-dependent. More-
over, despite the sequence and structural similarities between
the CS domain of Chp-1 and the N-terminal region of p23 (res-
idues 1–90), the CS domain of Chp-1 is essential but not suﬃ-
cient for Hsp90 binding. In comparison, the CS domain of
SGT1 alone can bind to Hsp90 in an ATP-independent man-
ner [16]. Therefore, three similar protein domains (p23, the
CS domains of SGT1 and Chp-1) display distinct ability to
interact with Hsp90, which may indicate the diﬀerence in their
correlated functions. Recent structural study indicates that the
SGT1-CS domain shares a b-sandwich fold of p23 [16]. More-
over, structural study on SGT1 and genetic mapping of p23
suggest that one surface (surface I) of SGT1 and p23 with in-
tense basic patches may be critical for their interaction with
Hsp90 [16,22,23]. It would be interesting to examine if the
CS domain of Chp-1 displays a similar b-sandwich fold and
charge distribution of the corresponding surface.
Two tandem repeated CHORD domains (CHORD-I and -
II), which are characterized by six cysteine and three histidine
residues, are the signature domains of CHORD-containing
proteins. It is likely that CHORD-containing proteins serve
important cellular functions in a conserved manner. This spec-
ulation is partially validated by our ﬁnding that like its plant
homolog RAR1, mammalian Chp-1 also binds to the N-termi-
nal ATPase domain of Hsp90 protein. However, the domains
of CHORD-containing proteins responsible for Hsp90 binding
appear to diﬀer across the phyla. The CHORD-I domain of
plant RAR1 protein is solely responsible for Hsp90 binding
[8,9]. In contrast, the CHORD-I domain of mammalian
Chp-1 protein is dispensable for Chp-1–Hsp90 interaction,
while the CHORD-II domain, the CS domain and the linker
sequence between two CHORD domains are essential. Giventhe fact that the corresponding CHORD sequences from diﬀer-
ent phyla share a higher sequence similarity than CHORD-I
and CHORD-II sequences within the same protein, our result
is somewhat unexpected. Structural study on Chp-1 will pro-
vide further insight into the molecular nature of Chp-1–
Hsp90 interaction and identiﬁcation of Chp-1s targets will
facilitate our understanding of the biological functions of this
important family of proteins.
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